La Cova de l'Avi (Vallirana, Barcelona) y el inicio del Neolítico final en el Nordeste de la Península Ibérica. Inhumaciones colectivas y nuevas redes de intercambio

[spa] Entre el Neolítico medio y el Neolítico final en el Nordeste de la Península Ibérica se producen cambios destacados en las pautas funerarias y en la cultura material de los grupos humanos, especialmente en los ajuares y lugares de enterramiento. Durante el Neolítico medio-reciente son típicas las inhumaciones primarias individuales en fosas con ajuares de cuentas de variscita, sílex melado, vasos cerámicos y puntualmente obsidiana. Por el contrario, durante el Neolítico final se generalizan las inhumaciones colectivas y sucesivas en cuevas y abrigos con ajuares que se caracterizan por la gran disminución de la variscita, sustituida por una gran variedad de colgantes y cuentas en piedra, concha y hueso. Ahora también aparecen las grandes láminas y los puñales de sílex, en ocasiones de procedencia extrapeninsular. La Cova de l'Avi representa en la actualidad el yacimiento cronológicamente más antiguo (c. 4700 BP) en el que se documentan estos nuevos comportamientos funerarios. [eng]The Middle to Late Neolithic transition in NE of Iberian Peninsula is characterized by changes on the mortuary behaviour and archaeological artifacts recorded in the luxury items in grave goods and inhumations cemeteries. Single or double primary burials associated with grave goods of variscite beads, honey flint and obsidian blades during Late Middle Neolithic are replaced for collective inhumations in cave and rock-shelters with grave goods composed mainly by shell, bone and stone beads and pendants, large flint blades and flint daggers coming outside de Iberian Peninsula. Cova de l'Avi represents the earlier site (c. 4700 BP) where these cultural changes and mortuary practices have been documented in NE of Iberi

Conclusiones y propuestas de manejo de las poblaciones y especies de anfibios y reptiles alóctonos en España

El criterio fundamental para considerar que una especie es alóctona en el territorio español se basa en la constatación de que la colonización no ha sido natural, sino de origen antrópico.Peer Reviewe

Material particulado en España: niveles, composición y contribución de fuentes

El estudio llevado a cabo en un elevado número de emplazamientos de medida de material particulado (PM) en España ha permitido determinar las importantes variaciones que se producen en los niveles medios de concentración de PM10 y PM2,5 y en su composición química, entre sus distintas regiones geográficas. En diferentes entornos industriales y de tráfico considerados “hotspots”, los niveles medios de PM10 registrados llegan a superar normalmente los valores límite de concentración recomendados. La variabilidad existente entre los distintos emplazamientos de medida en lo que se refiere a niveles de concentración de PM y a la superación de los valores límite de concentración está relacionada con la existencia de distintos patrones, tanto de emisión de las fuentes de material particulado naturales y antropogénicas, como patrones climáticos y de reactividad/ estabilidad de algunas especies presentes en la composición del PM.Este estudio ha sido financiado mediante convenios de colaboración de la Dirección General de Calidad y Evaluación Ambiental del Ministerio de Medio Ambiente y del Plan Nacional de I+D del Ministerio de Educación y Ciencia (CGL2004-05984_C07-02/CLI, REN2001-0659-C03-03), y contratos de investigación respaldados por Comunidades Autónomas de Andalucía, Cataluña, Madrid, y Valencia

Bladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation

BACKGROUND: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladder cancer patients, independent of tumor infiltration or treatment applied. We developed a Spanish version of the BCI, and assessed its acceptability and metric properties. METHODS: For the adaptation into Spanish we used the forward and back-translation method, expert panels, and cognitive debriefing patient interviews. For the assessment of metric properties we used data from 197 bladder cancer patients from a multi-center prospective study. The Spanish BCI and the SF-36 Health Survey were self-administered before and 12 months after treatment. Reliability was estimated by Cronbach's alpha. Construct validity was assessed through the multi-trait multi-method matrix. The magnitude of change was quantified by effect sizes to assess responsiveness. RESULTS: Reliability coefficients ranged 0.75-0.97. The validity analysis confirmed moderate associations between the BCI function and bother subscales for urinary (r = 0.61) and bowel (r = 0.53) domains; conceptual independence among all BCI domains (r ≤ 0.3); and low correlation coefficients with the SF-36 scores, ranging 0.14-0.48. Among patients reporting global improvement at follow-up, pre-post treatment changes were statistically significant for the urinary domain and urinary bother subscale, with effect sizes of 0.38 and 0.53. CONCLUSIONS: The Spanish BCI is well accepted, reliable, valid, responsive, and similar in performance compared to the original instrument. These findings support its use, both in Spanish and international studies, as a valuable and comprehensive tool for assessing quality of life across a wide range of bladder cancer patients

TFG 2016/2017

Amb aquesta publicació, EINA, Centre universitari de Disseny i Art adscrit a la Universitat Autònoma de Barcelona, dóna a conèixer el recull dels Treballs de Fi de Grau presentats durant el curs 2016-2017. Voldríem que un recull com aquest donés una idea més precisa de la tasca que es realitza a EINA per tal de formar nous dissenyadors amb capacitat de respondre professionalment i intel·lectualment a les necessitats i exigències de la nostra societat. El treball formatiu s’orienta a oferir resultats que responguin tant a paràmetres de rigor acadèmic i capacitat d’anàlisi del context com a l’experimentació i la creació de nous llenguatges, tot fomentant el potencial innovador del disseny.Con esta publicación, EINA, Centro universitario de diseño y arte adscrito a la Universidad Autónoma de Barcelona, da a conocer la recopilación de los Trabajos de Fin de Grado presentados durante el curso 2016-2017. Querríamos que una recopilación como ésta diera una idea más precisa del trabajo que se realiza en EINA para formar nuevos diseñadores con capacidad de responder profesional e intelectualmente a las necesidades y exigencias de nuestra sociedad. El trabajo formativo se orienta a ofrecer resultados que respondan tanto a parámetros de rigor académico y capacidad de análisis, como a la experimentación y la creación de nuevos lenguajes, al tiempo que se fomenta el potencial innovador del diseño.With this publication, EINA, University School of Design and Art, affiliated to the Autonomous University of Barcelona, brings to the public eye the Final Degree Projects presented during the 2016-2017 academic year. Our hope is that this volume might offer a more precise idea of the task performed by EINA in training new designers, able to speak both professionally and intellectually to the needs and demands of our society. The educational task is oriented towards results that might respond to the parameters of academic rigour and the capacity for contextual analysis, as well as to considerations of experimentation and the creation of new languages, all the while reinforcing design’s innovative potential

Famílies botàniques de plantes medicinals

Facultat de Farmàcia, Universitat de Barcelona. Ensenyament: Grau de Farmàcia, Assignatura: Botànica Farmacèutica, Curs: 2013-2014, Coordinadors: Joan Simon, Cèsar Blanché i Maria Bosch.Els materials que aquí es presenten són els recull de 175 treballs d’una família botànica d’interès medicinal realitzats de manera individual. Els treballs han estat realitzat per la totalitat dels estudiants dels grups M-2 i M-3 de l’assignatura Botànica Farmacèutica durant els mesos d’abril i maig del curs 2013-14. Tots els treballs s’han dut a terme a través de la plataforma de GoogleDocs i han estat tutoritzats pel professor de l’assignatura i revisats i finalment co-avaluats entre els propis estudiants. L’objectiu principal de l’activitat ha estat fomentar l’aprenentatge autònom i col·laboratiu en Botànica farmacèutica

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic

Measurement of t(t)over-bar normalised multi-differential cross sections in pp collisions at root s=13 TeV, and simultaneous determination of the strong coupling strength, top quark pole mass, and parton distribution functions

Peer reviewe

Measurement of the top quark forward-backward production asymmetry and the anomalous chromoelectric and chromomagnetic moments in pp collisions at √s = 13 TeV

Abstract The parton-level top quark (t) forward-backward asymmetry and the anomalous chromoelectric (d̂ t) and chromomagnetic (μ̂ t) moments have been measured using LHC pp collisions at a center-of-mass energy of 13 TeV, collected in the CMS detector in a data sample corresponding to an integrated luminosity of 35.9 fb−1. The linearized variable AFB(1) is used to approximate the asymmetry. Candidate t t ¯ events decaying to a muon or electron and jets in final states with low and high Lorentz boosts are selected and reconstructed using a fit of the kinematic distributions of the decay products to those expected for t t ¯ final states. The values found for the parameters are AFB(1)=0.048−0.087+0.095(stat)−0.029+0.020(syst),μ̂t=−0.024−0.009+0.013(stat)−0.011+0.016(syst), and a limit is placed on the magnitude of | d̂ t| &lt; 0.03 at 95% confidence level. [Figure not available: see fulltext.